Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08UOY
|
|||
Former ID |
DIB008193
|
|||
Drug Name |
Vadimezan
|
|||
Synonyms |
DMXAA; AS-1404; ASA-404; R-1564; 5,6-MeXAA; 5,6-dimethylxanthenone-4-acetic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 2 | [1] | |
Company |
Antisoma; University of Auckland
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H14O4
|
|||
Canonical SMILES |
CC1=C(C2=C(C=C1)C(=O)C3=CC=CC(=C3O2)CC(=O)O)C
|
|||
InChI |
1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)
|
|||
InChIKey |
XGOYIMQSIKSOBS-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 117570-53-3
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:75934
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01057342) Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer. U.S. National Institutes of Health. | |||
REF 2 | Auckland Cancer Society Research Centre report |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.